AlphaYouMS
Schedule 13G filing
MORGAN STANLEY disclosed a 12.2% stake in Arbutus Biopharma Corp (ABUS)
MORGAN STANLEY reported owning 12.2% of Arbutus Biopharma Corp (ABUS) (18,682,708 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.